Survival analysis of a phase IB/II study of everolimus and metformin for patients with advanced cancer.

e14020Background: Fundamental research suggests that a combination of everolimus and metformin has synergistic anti-tumour effects with lower chances of drug resistance. Methods: 9 patients with ad...